Walkner Condon Financial Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $398K | Buy |
3,586
+103
| +3% | +$11.4K | 0.07% | 187 |
|
|
2025
Q1 | $390K | Buy |
3,483
+31
| +0.9% | +$3.47K | 0.08% | 179 |
|
|
2024
Q4 | $319K | Buy |
3,452
+56
| +2% | +$5.17K | 0.06% | 208 |
|
|
2024
Q3 | $285K | Buy |
3,396
+286
| +9% | +$24K | 0.06% | 219 |
|
|
2024
Q2 | $213K | Buy |
3,110
+38
| +1% | +$2.61K | 0.05% | 242 |
|
|
2024
Q1 | $225K | Buy |
3,072
+61
| +2% | +$4.47K | 0.05% | 248 |
|
|
2023
Q4 | $244K | Buy |
3,011
+87
| +3% | +$7.05K | 0.06% | 232 |
|
|
2023
Q3 | $219K | Sell |
2,924
-254
| -8% | -$19K | 0.06% | 227 |
|
|
2023
Q2 | $245K | Buy |
3,178
+343
| +12% | +$26.4K | 0.06% | 206 |
|
|
2023
Q1 | $235K | Buy |
2,835
+213
| +8% | +$17.7K | 0.07% | 206 |
|
|
2022
Q4 | $225K | Buy |
+2,622
| New | +$225K | 0.07% | 207 |
|